Aadi Bioscience
Clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Learn more
Launch date
Employees
Market cap
CAD60.4m
Enterprise valuation
(CAD45m) (Public information from Sep 2024)
Share price
$1.83 AADI
Los Angeles California (HQ)
Authorizing premium user...